CXCL12 and T-cell acute lymphoblastic leukemia: Migration assays showed that BKT300 significantly inhibited the migration of leukemic cancer cell lines, including AML U937 cells (Fig. 1B) and acute T cell leukemia Jurkat cells (Fig. 1C), toward CXCL12.